PTG-300 in Subjects With Hereditary Hemochromatosis
Clinical trial NCT04202965 · COMPLETED
Trial details
- NCT number
- NCT04202965
- Sponsor
- Protagonist Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-19
- Primary completion
- 2021-10-06
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.